Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Hara

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroupYusuke Hara, Norio Shiba, Genki Yamato, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Drug Metabolism and Pharmacokinetics|December 18, 2024
Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal studySatoshi Mizuno, Shintaro Gake, Makiko Takabayashi, et al.
Pediatric Blood & Cancer|December 6, 2023
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factorTakahiro Aoki, Norio Shiba, Shinichi Tsujimoto, et al.
Blood|March 16, 2018
<i>RUNX1</i> mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosisGenki Yamato, Norio Shiba, Kenichi Yoshida, et al.
Genes, Chromosomes & Cancer|January 8, 2017
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndromeYusuke Hara, Norio Shiba, Kentaro Ohki, et al.
Haematologica|March 18, 2021
Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemiaTaeko Kaburagi, Genki Yamato, Norio Shiba, et al.
Genes, Chromosomes & Cancer|November 30, 2022
UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemiaTaeko Kaburagi, Norio Shiba, Genki Yamato, et al.
Blood Advances|January 10, 2022
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemiaGenki Yamato, Tomoko Kawai, Norio Shiba, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroupYusuke Hara, Norio Shiba, Genki Yamato, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Drug Metabolism and Pharmacokinetics|December 18, 2024
Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal studySatoshi Mizuno, Shintaro Gake, Makiko Takabayashi, et al.
Pediatric Blood & Cancer|December 6, 2023
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factorTakahiro Aoki, Norio Shiba, Shinichi Tsujimoto, et al.
Blood|March 16, 2018
<i>RUNX1</i> mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosisGenki Yamato, Norio Shiba, Kenichi Yoshida, et al.
Genes, Chromosomes & Cancer|January 8, 2017
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndromeYusuke Hara, Norio Shiba, Kentaro Ohki, et al.
Haematologica|March 18, 2021
Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemiaTaeko Kaburagi, Genki Yamato, Norio Shiba, et al.
Genes, Chromosomes & Cancer|November 30, 2022
UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemiaTaeko Kaburagi, Norio Shiba, Genki Yamato, et al.
Blood Advances|January 10, 2022
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemiaGenki Yamato, Tomoko Kawai, Norio Shiba, et al.
Pageof 14